期刊文献+

基于气相色谱-质谱联用的代谢组学用于黄连治疗Ⅱ型糖尿病的机理探索 被引量:32

Exploring the mechanism of Rhizoma coptidis in treating type Ⅱ diabetes mellitus based on metabolomics by gas chromatography-mass spectrometry
下载PDF
导出
摘要 将代谢组学的方法用于研究黄连治疗Ⅱ型糖尿病的机理。Ⅱ型糖尿病造模采用对大鼠灌胃脂肪乳并腹腔注射40 mg/kg链脲佐菌素的方法,大鼠分为正常组、模型组、黄连给药治疗组(10 g/kg)、二甲双胍给药治疗组(0.08g/kg)。大鼠给药30天后,采集血样用于生化指标的检测,采集24 h尿样用于代谢组学的分析。与模型组相比,糖尿病大鼠给药黄连30天后,空腹血糖值(FBG)显著降低了59.26%,总胆固醇(TC)降低了58.66%,甘油三酯(TG)降低了42.18%。采用气相色谱-质谱联用技术(GC-MS)对大鼠尿样中的内源性物质进行了相对含量测定,主成分分析结果表明,正常组与模型组显著分离,黄连组处于正常组与模型组之间,更接近于正常组。发现12个代谢物与糖尿病有关,包括4-甲基苯酚、苯甲酸、氨基丙二酸等。给药黄连后,其中的7个代谢物发生显著性回调,与氧化应激状态相关的氨基丙二酸和L-抗坏血酸出现向正常组显著性调节的趋势。这些结果表明,黄连不仅具有降糖和降血脂的作用,而且具有抗氧化作用,在一定程度上可能会抑制糖尿病合并症的发生和发展。 Metabolomics was used to explore the mechanism of Rhizoma coptidis in treating type Ⅱ diabetes mellitus. The rat model of type Ⅱ diabetes mellitus was constructed by an in jection of streptozocin (40 mg/kg), along with diets of fat emulsion. The rats were divided into four groups, the control group, the model group, the Rhizoma coptidis group ( 10 g/kg) and the metformin group (0.08 g/kg). After the treatment for 30 d, blood samples were collected to test biomedical indexes, and 24 h urine samples were collected for the metabolomics experiment. In the Rhizoma coptidis group, fasting blood glucose (FBG) , total cholesterol (TC) and total plasma triglycerides (TG) were significantly decreased by 59.26%, 58.66% and 42. 18%, respectively, compared with those in the model group. Based on gas chromatography-mass spectrometry, a urinary metabolomics method was used to study the mechanism of Rhizoma coptidis in treating diabetes mellitus. Based on the principal component analysis, it was found that the model group and control group were separated into two different clusters. The Rhizoma coptidis group was located between the model group and the control group, closer to the control group. Twelve significantly changed metabolites of diabetes mellitus were detected and identified, including 4-methyl phenol, benzoic acid, aminomalonic acid, and so on. After dia-betic rats were administered with Rhizoma coptidis, 7 metabolites were significantly changed, and L-ascorbic acid and aminomalonic acid which related with the oxidative stress were significantly regulated to normal. The pharmacological results showed that Rhizoma coptidis could display anti-hyperglycemic and anti-hyperlipidemic effects. The Rhizoma coptidis had antioxida- tion function in preventing the occurrence of complications with diabetes mellitus to some extent. The work illustrates that the metabolomics method is a useful tool to study the treatment mechanism of traditional Chinese medicine.
出处 《色谱》 CAS CSCD 北大核心 2012年第1期8-13,共6页 Chinese Journal of Chromatography
基金 国家科技部中国国际科学与技术合作项目(2009DFA21450) 国家自然科学基金项目(20805045)
关键词 代谢组学 气相色谱-质谱(GC-MS) 黄连 Ⅱ型糖尿病 中药 metabolomics gas chromatography-mass spectrometry (GC-MS) Rhizoma copti-dis typeⅡdiabetes mellitus traditional Chinese medicine
  • 相关文献

参考文献22

  • 1Lankinen M,Schwab U,Gopalacharyulu P V,et al.NutrMetab Cardiovas,2010,20:249.
  • 2Huo T G,Cai S,Lu X M,et al.J Pharm Biomed Anal,2009,49:976.
  • 3Zhang S X,Sun H,Sun W J,et al.J Pharm Biomed Anal,2010,53(4):1011.
  • 4Nicholson J K,Lindon J C,Holmes E.Xenobiotica,1999,29(11):1181.
  • 5何君,周宏灏.代谢组学及其在药理学中的进展[J].中国药理学通报,2006,22(11):1304-1309. 被引量:20
  • 6Nicholson J K,Connelly J,Lindon J C,et al.Nat Rev DrugDiscov,2002,1:153.doi:10.1038/nrd728.
  • 7Xu J J,Zhang J,Dong J Y,et al.Anal Bioanal Chem,2009,393:1657.
  • 8Yang J,Xu G W,Hong Q F,et al.J Chromatogr B,2004,813:53.
  • 9Bao Y Q,Zhao T,Wang X Y,et al.J Proteome Res,2009,8:1623.
  • 10Zhang Y F,Li X Y,Zou D J,et al.J Clin EndocrinolMetab,2008,93(7):2559.

二级参考文献27

  • 1黄玉荣,魏广力,龙红,肖淑华,王淑芳,刘昌孝.钩藤多动合剂的药效作用及用代谢物组学方法研究其生化机制[J].中草药,2005,36(3):398-402. 被引量:57
  • 2Phelps T J,Palumbo A V,Beliaev A S.Metabolomics and microarrays for improved understanding of phenotypic characteristics controlled by both genomics and environmental constraints[J].Curr Opin Biotechnol,2002,13:20-4.
  • 3Nicholson J K,Lindon J C,Holmes E.Metabonomics:understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data[J].Xenobiotica,1999,29:1181-9.
  • 4Nicholson J K,Connelly J,Lindon J C,et al.Metabonomics:a platform for studying drug toxicity and gene function[J],Nat Rev Drug Discov,2002,1:153 -61.
  • 5Griffin J L,Bollard M E.Metabonomics:Its potential as a tool in toxicology for safety assessment and data integration[J].Cur Drug Metab,2004,5:389-98.
  • 6Fiehn O,Kopka J,Dormann P,et al.Metabolite profiling for plant functional genomics[J].Nature Biotechnology,2000,18:1157 -61.
  • 7Nebert D W,Vesell E S.Advances in pharmacogenomics and individualized drug therapy:exciting challenges that lie ahead[J].Eur J Pharmacol,2004,500:267-80.
  • 8Ekins S,Nikolsky Y,Nikolskaya T.Techniques:Application of systems biology to absorption,distribution,metabolism,excretion and toxicity[J].Trends Pharmacol Sci,2005,26:202-9.
  • 9Antti H,Ebbelst M O,Keun H C,et al.Statistical experimental design and partial least squares regression analysis of biofluid metabonomic NMR and clinical chemistry data for screening of adverse drug effects[J].Chemom intell lab syst,2004,73:139-49.
  • 10Wilson I D,Plumb R,Granger J,et al.HPLC-MS-based methods for the study of metabonomics[J].J Chromatogr B Analyt Technol Biomed Life Sci,2005,817:67-76.

共引文献28

同被引文献497

引证文献32

二级引证文献239

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部